| Date Filed | Type | Description |
| 02/16/2016 |
SC 13G/A
| ALPINE ASSOCIATES MANAGEMENT INC. reports a 5% stake in Ocata Therapeutics, Inc. |
| 02/12/2016 |
SC 13G
| ALPINE ASSOCIATES MANAGEMENT INC. reports a 5.7% stake in Ocata Therapeutics, Inc. |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2016 |
4
| Myles Edward H (COO & CFO) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 56,000 shares
@ $8.5, valued at
$476k
Disposed/sold 140,000 options to buy
@ $7.78, valued at
$1.1M
Disposed/sold 112,000 options to buy
@ $8.49, valued at
$950.9k
|
|
| 02/11/2016 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 02/11/2016 |
4
| LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 02/11/2016 |
4
| Jooste H Le Roux (SVP of Bus Development & CCO) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 25,000 shares
@ $8.5, valued at
$212.5k
Disposed/sold 75,000 options to buy
@ $6.32, valued at
$474k
|
|
| 02/11/2016 |
4
| SHAPIRO ALAN C (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 02/11/2016 |
4
| Anglade Eddy (Chief Medical Officer) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 56,000 shares
@ $8.5, valued at
$476k
Disposed/sold 100,000 options to buy
@ $8.99, valued at
$899k
Disposed/sold 112,000 options to buy
@ $8.49, valued at
$950.9k
Unknown transaction of 56,000 shares
@ $8.5, valued at
$476k
Disposed/sold 100,000 options to buy
@ $8.99, valued at
$899k
Disposed/sold 112,000 options to buy
@ $8.49, valued at
$950.9k
|
|
| 02/11/2016 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 31,000 shares
@ $8.5, valued at
$263.5k
Disposed/sold 3,621 options to buy
@ $8, valued at
$29k
Disposed/sold 5,000 options to buy
@ $5.79, valued at
$29k
Disposed/sold 1,250 options to buy
@ $6, valued at
$7.5k
Disposed/sold 10,000 options to buy
@ $6.17, valued at
$61.7k
Disposed/sold 100,000 options to buy
@ $7.94, valued at
$794k
Disposed/sold 10,000 options to buy
@ $6.39, valued at
$63.9k
Disposed/sold 5,000 options to buy
@ $8.36, valued at
$41.8k
Unknown transaction of 31,000 shares
@ $8.5, valued at
$263.5k
Disposed/sold 3,621 options to buy
@ $8, valued at
$29k
Disposed/sold 5,000 options to buy
@ $5.79, valued at
$29k
|
|
| 02/11/2016 |
4
| LOSHITZER ZOHAR (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 02/11/2016 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 02/11/2016 |
4
| Wotton Paul K (President and CEO) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Unknown transaction of 277,500 shares
@ $8.5, valued at
$2.4M
Disposed/sold 300,000 options to buy
@ $6.55, valued at
$2M
Unknown transaction of 277,500 shares
@ $8.5, valued at
$2.4M
Disposed/sold 300,000 options to buy
@ $6.55, valued at
$2M
|
|
| 02/11/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2016 |
8-K
| Quarterly results |
| 02/10/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/10/2016 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 01/04/2016 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 01/04/2016 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Ocata Therapeutics, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $8.36, valued at
$83.6k
Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $8.36, valued at
$83.6k
|
|
| 01/04/2016 |
4
| LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 01/04/2016 |
4
| LOSHITZER ZOHAR (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 01/04/2016 |
4
| PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 01/04/2016 |
4
| SHAPIRO ALAN C (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 12/18/2015 |
8-K
| Form 8-K - Current report |
| 11/10/2015 |
4
| Lanza Robert (Chief Scientific Officer) has filed a Form 4 on Ocata Therapeutics, Inc. |
| 11/10/2015 |
8-K
| Form 8-K - Current report |
| 11/09/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 10/01/2015 |
4
| LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc. |
|